Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0132 | 0.0173 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.1233 | 0.371 | 1 |
Giardia lamblia | Transglutaminase/protease, putative | 0.1233 | 0.371 | 1 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0326 | 0.0913 | 0.228 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0059 | 0.0087 | 0.1103 |
Brugia malayi | Thioredoxin family protein | 0.1233 | 0.371 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0076 | 0.0019 |
Giardia lamblia | Hypothetical protein | 0.1233 | 0.371 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0132 | 0.0154 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0167 | 0.0421 | 0.0947 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0086 | 0.0231 |
Schistosoma mansoni | hypothetical protein | 0.1233 | 0.371 | 1 |
Plasmodium falciparum | flap endonuclease 1 | 0.0059 | 0.0087 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0167 | 0.0421 | 0.0947 |
Mycobacterium ulcerans | putative transglutaminase-like protein | 0.1233 | 0.371 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0076 | 0.0019 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0086 | 0.0045 |
Mycobacterium tuberculosis | Conserved protein | 0.1233 | 0.371 | 1 |
Trichomonas vaginalis | peptide N-glycanase, putative | 0.1233 | 0.371 | 1 |
Brugia malayi | Flap endonuclease-1 | 0.0059 | 0.0087 | 0.0234 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.0787 | 0.1955 |
Mycobacterium leprae | Conserved hypothetical protein | 0.1233 | 0.371 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.1233 | 0.371 | 1 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0059 | 0.0087 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.0787 | 1 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 1 |
Mycobacterium ulcerans | transglutaminase family protein | 0.1233 | 0.371 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0167 | 0.0421 | 0.0947 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0076 | 0.0972 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0159 | 0.0398 | 0.0742 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.0421 | 0.5346 |
Loa Loa (eye worm) | hypothetical protein | 0.0167 | 0.0421 | 0.5346 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0132 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.1233 | 0.371 | 1 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0059 | 0.0087 | 0.0028 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0059 | 0.0087 | 0.6561 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0326 | 0.0913 | 0.5 |
Brugia malayi | hypothetical protein | 0.0286 | 0.0787 | 0.2121 |
Mycobacterium ulcerans | hypothetical protein | 0.1233 | 0.371 | 1 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0086 | 0.0045 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0059 | 0.0087 | 0.6561 |
Mycobacterium tuberculosis | Long conserved protein | 0.1233 | 0.371 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Mycobacterium ulcerans | hypothetical protein | 0.1233 | 0.371 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0132 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0326 | 0.0913 | 0.228 |
Brugia malayi | Muscleblind-like protein | 0.0167 | 0.0421 | 0.1134 |
Echinococcus granulosus | flap endonuclease 1 | 0.0059 | 0.0087 | 0.0028 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0076 | 0.0206 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0059 | 0.0087 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0132 | 0.0154 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0059 | 0.0087 | 1 |
Mycobacterium leprae | Conserved hypothetical protein | 0.1233 | 0.371 | 1 |
Echinococcus multilocularis | Transglutaminase | 0.1233 | 0.371 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.0787 | 0.1955 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0076 | 0.0019 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0132 | 0.0173 |
Echinococcus granulosus | Transglutaminase | 0.1233 | 0.371 | 1 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0159 | 0.0398 | 0.0742 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 2.2387 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.